MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
巨噬细胞激活
基本信息
- 批准号:2067925
- 负责人:
- 金额:$ 13.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-08-01 至 1997-07-31
- 项目状态:已结题
- 来源:
- 关键词:MHC class II antigen RNase protection assay Salmonella typhimurium antireceptor antibody antisense nucleic acid bactericidal immunity bioassay enzyme linked immunosorbent assay gene expression immunofluorescence technique inhibitor /antagonist laboratory mouse leukocyte activation /transformation macrophage monokines neurotransmitter receptor nucleic acid sequence phagocytosis polymerase chain reaction radioimmunoassay receptor expression recombinant proteins substance P tachykinin tissue /cell culture
项目摘要
DESCRIPTION: (Adapted from the Applicant's abstract): Macrophages are
critically important for phagocytosis and killing of microbes, for
secreting cytokines to activate leukocytes, and for presenting antigen
to MHC compatible T lymphocytes. Since activated macrophages perform
these functions with much greater efficiency, understanding the events
required to activate these cells is of considerable importance. While
cytokines, such as interferon-gamma, have important macrophage
activating factors, little attention has been given to the peptide,
substance P. This peptide is found in tissues undergoing inflammatory
processes and in normal lymphoid tissues. It is also clear that
macrophages express substance P receptors. The overall goal of this
project is to determine the significance of substance P production and
substance P receptor expression by macrophages using in vitro and in
vivo models of macrophage activation. Specifically, nuclease protection
assays and radioimmunoassays will be performed to quantify
preprotachykinin mRNA expression and substance P secretion, respectively.
These studies are of extreme importance since they challenge the current
view that substance P is solely a product of neuronal cells. The
ability of macrophages to secrete substance P and express receptors for
this peptide suggest that autocrine mechanisms can occur.
Unfortunately, it is not possible to definitively address the role of
substance P receptor expression in macrophage activation since reagents
to detect this receptor are not available. To this end, the murine
macrophage substance P receptor will be sequenced using the dideoxy
chain termination method, and cloned receptor fragments used to develop
sensitive quantitative competitive-reverse transcribed PCR (QC-RT-PCR).
These assays will quantify receptor mRNA expressed by macrophages
activated in vitro or in vivo. Using a protein expression system, it
will be possible to express recombinant receptor protein for use as an
immunogen. Antibodies specific for the macrophage substance P receptor
and I-125 labelled substance P will be used to quantify receptor
expression on macrophages activated in vitro and in vivo. The ability
of activated macrophages to up regulate substance P receptors, strongly
suggests a role in macrophage activation. To prove this hypothesis, the
effect substance P has on several critical macrophage functions will be
determined. These functions include: 1) phagocytosis and killing of
Salmonella typhimurium; 2) expression of monokine, class II MHC, and
substance P receptor mRNAs as quantified by QC-RT-PCR; 3) secretion of
monokines quantified by ELISA and bioassays; and 4) cell surface
expression of class II MHC and substance P receptor proteins using
immunofluorescence. To prove specificity and significance of the
substance P induced effects, antagonists of the response will be used.
These antagonists will include: 1) a peptide antagonist (Spantide II);
2) anti-substance P receptor antibodies; and 3) anti-sense
oligonucleotides. Ultimately the ability of substance P antagonists to
increase the pathogenicity of the intracellular pathogen, Salmonella
typhimurium, will be determined using a murine model. Together these
studies are likely to demonstrate that the substance P- substance P
receptor interaction is one of considerable importance for the
activation of macrophages.
描述:(改编自申请人的摘要):巨噬细胞是
对于微生物的吞噬作用和杀灭作用至关重要
分泌细胞因子激活白细胞并呈递抗原
MHC 相容性 T 淋巴细胞。 由于激活的巨噬细胞执行
这些功能的效率更高,可以理解事件
激活这些细胞所需的物质非常重要。 尽管
细胞因子,例如干扰素-γ,对巨噬细胞具有重要作用
激活因子,但很少有人关注肽,
P 物质。这种肽存在于发生炎症的组织中
过程和正常淋巴组织中。 还清楚的是
巨噬细胞表达 P 物质受体。 本次活动的总体目标
项目的目的是确定 P 物质生产的重要性和
巨噬细胞在体外和体内表达 P 物质受体
巨噬细胞激活的体内模型。 具体来说,核酸酶保护
将进行化验和放射免疫测定来量化
分别是前原速激肽 mRNA 表达和 P 物质分泌。
这些研究极其重要,因为它们挑战了当前的
认为 P 物质只是神经元细胞的产物。 这
巨噬细胞分泌 P 物质和表达 P 物质受体的能力
该肽表明可以发生自分泌机制。
不幸的是,不可能明确地说明
P物质受体表达在巨噬细胞激活自试剂中的应用
无法检测到该受体。 为此,小鼠
巨噬细胞 P 物质受体将使用双脱氧酶进行测序
链终止方法,以及用于开发的克隆受体片段
敏感定量竞争性逆转录 PCR (QC-RT-PCR)。
这些测定将量化巨噬细胞表达的受体 mRNA
在体外或体内激活。 使用蛋白质表达系统,
将有可能表达重组受体蛋白用作
免疫原。 巨噬细胞 P 物质受体特异性抗体
I-125标记的P物质将用于定量受体
在体外和体内激活的巨噬细胞上表达。 能力
激活的巨噬细胞上调 P 物质受体,强烈
表明在巨噬细胞激活中发挥作用。 为了证明这个假设,
P 物质对巨噬细胞几个关键功能的影响
决定。 这些功能包括:1)吞噬和杀伤
鼠伤寒沙门氏菌; 2) 单核因子、II类MHC的表达,以及
通过 QC-RT-PCR 定量的 P 物质受体 mRNA; 3)分泌
通过 ELISA 和生物测定法定量单核因子; 4) 细胞表面
II 类 MHC 和 P 物质受体蛋白的表达
免疫荧光。 证明其特殊性和意义
P物质引起的效应,会使用该反应的拮抗剂。
这些拮抗剂包括: 1) 肽拮抗剂 (Spantide II);
2)抗P物质受体抗体; 3)反义
寡核苷酸。最终 P 物质拮抗剂的能力
增加细胞内病原体沙门氏菌的致病性
鼠伤寒杆菌,将使用小鼠模型进行测定。 一起这些
研究很可能证明 P 物质- P 物质
受体相互作用对于
巨噬细胞的激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH L BOST其他文献
KENNETH L BOST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH L BOST', 18)}}的其他基金
Platform for practical delivery of oral autoantigens as co-therapies for neurolog
口腔自身抗原作为神经科患者联合疗法的实际递送平台
- 批准号:
8640510 - 财政年份:2014
- 资助金额:
$ 13.65万 - 项目类别:
Induced Autoantigen Expression Exacerbates EAE
诱导自身抗原表达加剧 EAE
- 批准号:
8013914 - 财政年份:2010
- 资助金额:
$ 13.65万 - 项目类别:
Induced Autoantigen Expression Exacerbates EAE
诱导自身抗原表达加剧 EAE
- 批准号:
7779144 - 财政年份:2010
- 资助金额:
$ 13.65万 - 项目类别:
MDMA alters immunity to infections of the peripheral and central nervous systems
MDMA 改变对周围和中枢神经系统感染的免疫力
- 批准号:
7389648 - 财政年份:2007
- 资助金额:
$ 13.65万 - 项目类别:
MDMA alters immunity to infections of the peripheral and central nervous systems
MDMA 改变对周围和中枢神经系统感染的免疫力
- 批准号:
7798952 - 财政年份:2007
- 资助金额:
$ 13.65万 - 项目类别:
MDMA alters immunity to infections of the peripheral and central nervous systems
MDMA 改变对周围和中枢神经系统感染的免疫力
- 批准号:
7608715 - 财政年份:2007
- 资助金额:
$ 13.65万 - 项目类别:
MDMA alters immunity to infections of the peripheral and central nervous systems
MDMA 改变对周围和中枢神经系统感染的免疫力
- 批准号:
7251076 - 财政年份:2007
- 资助金额:
$ 13.65万 - 项目类别:
Edible adjuvant expressed in transgenic soybeans
转基因大豆中表达的食用佐剂
- 批准号:
6814707 - 财政年份:2004
- 资助金额:
$ 13.65万 - 项目类别:
An edible adjuvant expressed in transgenic soybeans
转基因大豆中表达的食用佐剂
- 批准号:
6953761 - 财政年份:2004
- 资助金额:
$ 13.65万 - 项目类别:
Limited IL-12B2 receptor expression during salmonellosis
沙门氏菌病期间 IL-12B2 受体表达有限
- 批准号:
6632243 - 财政年份:2001
- 资助金额:
$ 13.65万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 13.65万 - 项目类别:














{{item.name}}会员




